Drug Guide


    Used only if resistance to all other agents, or if T315I mutation
    • Mechanism of Action
    • Inhibit the Bcr-Abl tyrosine kinase as well as the stem cell receptor factor (cKIT) and several other receptor tyrosine kinases.

Clinical Use

    • Indication
    • Chronic myeloid leukaemia with resistance or intolerance to at least two other tyrosine kinase inhibitors, other with T315I mutation
    • Adverse Effects
    • Rash
    • Fatigue
    • Oedema
    • Nausea / vomiting / diarrhoea
    • Muscle cramping
    • Peripheral neuropathy
    • LFT derangement
    • Myelosuppression - anaemia, neutropaenia, thrombocytopaenia
    • Cardiovascular - cardiac ischaemia, stroke, peripheral vascular disease, hypercholesterolaemia
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge